Public Workshop: FDA/AAO Workshop on Developing Novel Endpoints for Premium Intraocular Lenses, March 28, 2014
The Food and Drug Administration (FDA) announced the following co-sponsored public workshop entitled "FDA/American Academy of Ophthalmology (AAO) Workshop on Developing Novel Endpoints for Premium Intraocular Lenses.”
The purpose of this workshop was to discuss current challenges in the assessment of innovative intraocular lens (IOL) designs with a focus on endpoint methodologies used in evaluating IOL safety and effectiveness. The primary goal of the workshop was to improve the regulatory science around the approval of premium IOLs and the efficiency with which they get to market.
This meeting was held March 28, 2014, beginning at 8:30 a.m. at the following location:
FDA White Oak Campus, 10903 New Hampshire Avenue, Bldg. 31, Room 1503, Silver Spring, MD, 20993
Registration is $250 for Academy members, $400 for non-members and available on a first-come, first-served basis. Persons interested in attending this public workshop must register online. The deadline for registration is March 27, 2014 at 5:00 p.m. EDT. There will be no on-site registration on the day of the public workshop. Early registration is recommended because facilities are limited and, therefore FDA may limit the number of participants from each organization. To register for the public workshop, please visit the American Academy of Ophthalmology (AAO) website: www.aao.org/IOLworkshop
Those interested in attending but are unable or unwilling to access the electronic registration site should fax the PDF form on the AAO website to (415) 561-8575. Those without internet access should contact AAO Customer Service to register at (415) 561-8540 or (866) 561-8558 (toll free). Please provide complete contact information for each attendee, including name, title, affiliation, address, email, and telephone number. If there are any questions with registration, please contact the AAO administrative offices at (415) 561-8540. Registrants will receive confirmation after they have been accepted. You will be notified if you are on a waiting list.
If you require special accommodations due to a disability, or need additional information regarding registration, please contact Susan Monahan, Office of Communications and Education, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 66, Silver Spring, MD 20993, 301-796-5661, FAX: 301-847-8142, email@example.com.
For questions regarding workshop content please contact Dr. Michelle Tarver, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 2504, Silver Spring, MD 20993-0002, 301-796-5620, email: firstname.lastname@example.org.